医药行业分析
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
- (2022-01-21)
治疗成人T细胞白血病/淋巴瘤(ATL)的创新药!第一 第三 第一个EZH1/EZH2的双重抑制剂 valemetostat 在日本申请上市!
(2022-01-21)- (2022-01-21)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-20)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-19)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-18)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-17)
- (2022-01-16)
- (2022-01-16)
- (2022-01-16)
- (2022-01-16)
- (2022-01-15)
- (2022-01-15)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)
- (2022-01-14)